Yoo S, et al. - Researchers here analyzed the prognostic factors and outcomes for patients with stage I or II endometrial adenocarcinoma in the National Cancer Institute’s Surveillance, Epidemiology, and End Results public database. In the current work, the delivery of brachytherapy, compared with external-beam radiation therapy (EBRT) alone, was not associated with enhanced survival among patients with early-stage endometrial cancer managed without hysterectomy.